PT - JOURNAL ARTICLE AU - Takiy-Eddine Berrandou AU - David Balding AU - Doug Speed TI - LDAK-GBAT: fast and powerful gene-based association testing using summary statistics AID - 10.1101/2022.07.01.22277161 DP - 2022 Jan 01 TA - medRxiv PG - 2022.07.01.22277161 4099 - http://medrxiv.org/content/early/2022/07/05/2022.07.01.22277161.short 4100 - http://medrxiv.org/content/early/2022/07/05/2022.07.01.22277161.full AB - We present LDAK-GBAT, a novel tool for gene-based association testing using summary statistics from genome-wide association studies. We first evaluate LDAK-GBAT using ten phenotypes from the UK Biobank. We show that LDAK-GBAT is computationally efficient, taking approximately 30 minutes to analyze imputed data (2.9M common, genic SNPs), and requiring less than 10Gb memory. In total, LDAK-GBAT finds 680 genome-wide significant genes (P≤2.8×10−6), which is at least 25% more than each of five existing tools (MAGMA, GCTA-fastBAT, sumFREGAT-SKAT-O, sumFREGAT-PCA and sumFREGAT-ACAT), and 48% more than found by single-SNP analysis. We then analyze 99 additional phenotypes from the UK Biobank, the Million Veterans Project and the Psychiatric Genetics Consortium. In total, LDAK-GBAT finds 7957 significant genes, which is at least 24% more than the best existing tools, and 42% more than found by single-SNP analysis.Competing Interest StatementThe authors have declared no competing interest.Funding StatementT-E.B. and D.S. are supported by Aarhus University Research Foundation (AUFF), by the Independent Research Fund Denmark (Project no. 7025-00094B), and by a Lundbeck Foundation Experiment Grant. D.B. and D.S. are supported from the Australian Research Council (Grant DP190103188).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics committee of North West Multi-centre Research gave ethical approval for this work. To elaborate, this study only used human data from UK Biobank, whose website states the following: “UK Biobank has approval from the North West Multi-centre Research Ethics Committee (MREC) as a Research Tissue Bank (RTB) approval. This approval means that researchers do not require separate ethical clearance and can operate under the RTB approval (there are certain exceptions to this which are set out in the Access Procedures, such as re-contact applications).” More details are provided at https://www.ukbiobank.ac.uk/learn-more-about-uk-biobank/about-us/ethics).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThis study used only previously-collected data, that are either freely available or can be applied for. Specifically, UK Biobank data can be applied for from www.ukbiobank.ac.uk. website, Million Veterans Project summary statistics can be applied for from https://www.ncbi.nlm.nih.gov/gap, and Psychiatric Genomics Consortium summary statistics can be downloaded from https://www.med.unc.edu/pgc/download-results.